Pharmacophore and QSAR Modeling of Neuronal Nitric Oxide Synthase Ligands and Subsequent Validation and In Silico Search for New Scaffolds

Publisher： Bentham Science Publishers

E-ISSN： 1875-6638|12|4|371-393

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.12, Iss.4, 2016-06, pp. : 371-393

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective Neuronal Nitric Oxide Synthase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 7, 2005-07 ,pp. : 603-624

Bentham Science Publishers

Access to resources Recommend Favorite

On the selectivity of 7-nitroindazole as an inhibitor of neuronal nitric oxide synthase

By Reiner A.   Zagvazdin Y.  

Trends in Pharmacological Sciences, Vol. 19, Iss. 9, 1998-09 ,pp. : 348-350

Elsevier

Access to resources Recommend Favorite

Selective Inhibition of Neuronal Nitric Oxide Synthase by L-Arginine Derivatives

By  

Letters in Drug Design & Discovery, Vol. 5, Iss. 1, 2008-01 ,pp. : 36-38

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances Toward Improving the Bioavailability of Neuronal Nitric Oxide Synthase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 7, 2013-04 ,pp. : 803-812

Bentham Science Publishers

Access to resources Recommend Favorite

Development of a Predictive Pharmacophore Model and a 3D-QSAR Study for an in silico Screening of New Potent Bcr-Abl Kinase Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 17, Iss. 3, 2017-01 ,pp. : 188-204

Bentham Science Publishers

Access to resources Recommend Favorite